CD4 and B-cell chronic lymphocytic leukemia: Increased expression of PD-1 in blood-derived CD4+ T cells has been reported for CLL [1, 6–8] and other B-cell non-Hodgkin lymphomas (B-NHL), including diffuse large B-cell lymphoma (DLBCL) [9, 10].